688578 艾力斯
已收盘 07-01 15:00:00
资讯
新帖
简况
6月29日艾力斯涨14.49%，中欧医疗健康混合A基金重仓该股
证券之星 · 06-29 16:41
6月29日艾力斯涨14.49%，中欧医疗健康混合A基金重仓该股
艾力斯涨14.49%，中邮证券一个月前给出“买入”评级
证券之星 · 06-29 16:41
艾力斯涨14.49%，中邮证券一个月前给出“买入”评级
艾力斯：公司已于2026年5月26日披露了《上海艾力斯医药科技股份有限公司2025年年度权益分派实施公告》
证券之星 · 06-24
艾力斯：公司已于2026年5月26日披露了《上海艾力斯医药科技股份有限公司2025年年度权益分派实施公告》
6月24日艾力斯涨6.64%，中欧医疗健康混合A基金重仓该股
证券之星 · 06-24
6月24日艾力斯涨6.64%，中欧医疗健康混合A基金重仓该股
艾力斯涨6.64%，中邮证券一个月前给出“买入”评级
证券之星 · 06-24
艾力斯涨6.64%，中邮证券一个月前给出“买入”评级
艾力斯：伏美替尼III期临床研究已于2025年一季度完成患者入组
证券之星 · 06-03
艾力斯：伏美替尼III期临床研究已于2025年一季度完成患者入组
每周股票复盘：艾力斯（688578）每股派现0.60元含税
证券之星 · 05-31
每周股票复盘：艾力斯（688578）每股派现0.60元含税
药捷安康-B(02617)与艾力斯达成临床合作及供药协议
智通财经 · 05-26
药捷安康-B(02617)与艾力斯达成临床合作及供药协议
艾力斯（688578）披露2025年年度权益分派实施公告，5月25日股价下跌2.05%
证券之星 · 05-25
艾力斯（688578）披露2025年年度权益分派实施公告，5月25日股价下跌2.05%
每周股票复盘：艾力斯（688578）2025年度股东会多项议案获通过
证券之星 · 05-17
每周股票复盘：艾力斯（688578）2025年度股东会多项议案获通过
中邮证券：给予艾力斯买入评级
证券之星 · 05-09
中邮证券：给予艾力斯买入评级
【机构调研记录】蜂巢基金调研艾力斯
证券之星 · 04-28
【机构调研记录】蜂巢基金调研艾力斯
每周股票复盘：艾力斯（688578）Q1净利增54.94%
证券之星 · 04-26
每周股票复盘：艾力斯（688578）Q1净利增54.94%
艾力斯(688578.SH)发布一季度业绩，归母净利润6.36亿元，同比增长54.94%
智通财经 · 04-22
艾力斯(688578.SH)发布一季度业绩，归母净利润6.36亿元，同比增长54.94%
艾力斯（688578）披露2026年第一季度报告，4月22日股价上涨2.16%
证券之星 · 04-22
艾力斯（688578）披露2026年第一季度报告，4月22日股价上涨2.16%
3月27日艾力斯涨5.71%，银华中证创新药产业ETF基金重仓该股
证券之星 · 03-27
3月27日艾力斯涨5.71%，银华中证创新药产业ETF基金重仓该股
股市必读：3月13日艾力斯现1笔大宗交易 机构净卖出1521.61万元
证券之星 · 03-16
股市必读：3月13日艾力斯现1笔大宗交易 机构净卖出1521.61万元
每周股票复盘：艾力斯（688578）一周现3笔大宗交易
证券之星 · 03-15
每周股票复盘：艾力斯（688578）一周现3笔大宗交易
3月13日艾力斯现1笔大宗交易 机构净卖出1521.61万元
证券之星 · 03-13
3月13日艾力斯现1笔大宗交易 机构净卖出1521.61万元
3月12日艾力斯现1笔大宗交易 机构净买入948.6万元
证券之星 · 03-12
3月12日艾力斯现1笔大宗交易 机构净买入948.6万元
加载更多
公司概况
公司名称：
上海艾力斯医药科技股份有限公司
所属行业：
医药制造业
上市日期：
2020-12-02
主营业务：
上海艾力斯医药科技股份有限公司的主营业务是肿瘤靶向创新药的研发、生产和营销。公司的主要产品是甲磺酸伏美替尼片、枸橼酸戈来雷塞片、普拉替尼胶囊。
发行价格：
22.73
{"stockData":{"symbol":"688578","market":"SH","secType":"STK","nameCN":"艾力斯","latestPrice":125.81,"timestamp":1782889200000,"preClose":109.2,"halted":0,"volume":19425801,"delay":0,"changeRate":0.1521,"floatShares":450000000,"shares":450000000,"eps":5.3659,"marketStatus":"已收盘","change":16.61,"latestTime":"07-01 15:00:00","open":108,"high":125.98,"low":105.01,"amount":2260000000,"amplitude":0.192,"askPrice":125.82,"askSize":182,"bidPrice":125.81,"bidSize":117,"shortable":0,"etf":0,"ttmEps":5.3659,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782955800000},"marketStatusCode":5,"adr":0,"adjPreClose":109.2,"symbolType":"stock_kcb","openAndCloseTimeList":[[1782869400000,1782876600000],[1782882000000,1782889200000]],"highLimit":120.12,"lowLimit":98.28,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":450000000,"isCdr":false,"pbRate":7.31,"roa":"--","peRate":23.446207,"roe":"8.59%","epsLYR":4.86,"committee":-0.227766,"marketValue":56615000000,"turnoverRate":0.0432,"status":0,"afterMarket":{"amount":0,"volume":0,"close":125.81,"buyVolume":950,"sellVolume":0,"time":1782891237746,"indexStatus":"已收盘 07-01 15:30:00","preClose":109.2},"floatMarketCap":56615000000},"requestUrl":"/m/hq/s/688578","defaultTab":"news","newsList":[{"id":"2647322848","title":"6月29日艾力斯涨14.49%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322848","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322848?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:41","pubTimestamp":1782722472,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日艾力斯涨14.49%创60日新高，收盘报107.01元，换手率3.92%，成交量17.64万手，成交额18.22亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共38家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.703，较上一交易日下跌1.34%，近一年上涨2.14%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159760","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322361","title":"艾力斯涨14.49%，中邮证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322361","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322361?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:41","pubTimestamp":1782722464,"startTime":"0","endTime":"0","summary":"今日艾力斯涨14.49%，收盘报107.01元。2026年5月9日，中邮证券研究员盛丽华,陈灿发布了对艾力斯的研报《Q1业绩超预期，产品矩阵逐步成型》，该研报对艾力斯给出“买入”评级。公司深耕肺癌市场商业化成绩显著，考虑伏美替尼仍有20外插与辅助治疗等适应症拓展空间，维持“买入”评级。艾力斯个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645349899","title":"艾力斯：公司已于2026年5月26日披露了《上海艾力斯医药科技股份有限公司2025年年度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2645349899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645349899?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:30","pubTimestamp":1782293440,"startTime":"0","endTime":"0","summary":"证券之星消息，艾力斯06月24日在投资者关系平台上答复投资者关心的问题。公司始终重视广大投资者的长期回报，致力于与投资者共享公司发展成果，公司已于2026年5月26日披露了《上海艾力斯医药科技股份有限公司2025年年度权益分派实施公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400031950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","688578","BK1574","BK1515","BK1161","BK0239","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645389590","title":"6月24日艾力斯涨6.64%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645389590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645389590?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:40","pubTimestamp":1782290425,"startTime":"0","endTime":"0","summary":"证券之星消息，6月24日艾力斯涨6.64%，收盘报93.5元，换手率2.35%，成交量10.57万手，成交额9.91亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共38家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.6285，较上一交易日上涨1.96%，近一年下跌2.34%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400030102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645895910","title":"艾力斯涨6.64%，中邮证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2645895910","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645895910?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:40","pubTimestamp":1782290415,"startTime":"0","endTime":"0","summary":"今日艾力斯涨6.64%，收盘报93.5元。2026年5月9日，中邮证券研究员盛丽华,陈灿发布了对艾力斯的研报《Q1业绩超预期，产品矩阵逐步成型》，该研报对艾力斯给出“买入”评级。公司深耕肺癌市场商业化成绩显著，考虑伏美替尼仍有20外插与辅助治疗等适应症拓展空间，维持“买入”评级。艾力斯个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400030100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640218972","title":"艾力斯：伏美替尼III期临床研究已于2025年一季度完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2640218972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640218972?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:27","pubTimestamp":1780475254,"startTime":"0","endTime":"0","summary":"证券之星消息，艾力斯06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，伏美替尼单药一线治疗表皮生长因子受体20号外显子插入突变晚期非小细胞肺癌的国际多中心III期临床研究当前进展如何？艾力斯回复：尊敬的投资者您好，公司与ArriVent合作开发的伏美替尼适用于EGFR 20外显子插入突变NSCLC一线治疗的全球、多中心、III 期临床研究已于2025年一季度完成患者入组，目前处于随访阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300033189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639040996","title":"每周股票复盘：艾力斯（688578）每股派现0.60元含税","url":"https://stock-news.laohu8.com/highlight/detail?id=2639040996","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639040996?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:20","pubTimestamp":1780172422,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，艾力斯报收于89.72元，较上周的92.26元下跌2.75%。本周，艾力斯5月25日盘中最高价报92.28元。5月29日盘中最低价报87.4元，股价触及近一年最低点。本周关注点公司公告汇总：艾力斯2025年年度权益分派实施，每股派发现金红利0.60元（含税）。股权登记日为2026年5月29日，除权（息）日为2026年6月1日，现金红利发放日为2026年6月1日。分派对象为截至股权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638510519","title":"药捷安康-B(02617)与艾力斯达成临床合作及供药协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2638510519","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638510519?lang=zh_cn&edition=full","pubTime":"2026-05-26 21:30","pubTimestamp":1779802215,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B 公布，公司与上海艾力斯医药科技股份有限公司(艾力斯)达成临床合作及供药协议。根据协议条款，药捷安康作为本临床试验的申办方，承担本临床试验的运营与费用。艾力斯免费提供本临床试验所需要的甲磺酸伏美替尼片。截至2025年12月31日，公司已完成 I期临床试验，TT-00973耐受性良好，并在部分的实体肿瘤患者中观察到临床疗效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688578","BK1161","02617","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638551845","title":"艾力斯（688578）披露2025年年度权益分派实施公告，5月25日股价下跌2.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638551845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638551845?lang=zh_cn&edition=full","pubTime":"2026-05-25 22:22","pubTimestamp":1779718943,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，艾力斯报收于90.37元，较前一交易日下跌2.05%，最新总市值为406.66亿元。该股当日开盘92.09元，最高92.28元，最低90.2元，成交额达3.63亿元，换手率为0.89%。近日，上海艾力斯医药科技股份有限公司发布《2025年年度权益分派实施公告》。股权登记日为2026年5月29日，除权（息）日为2026年6月1日，现金红利发放日为2026年6月1日。分派对象为截至股权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500034046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636612810","title":"每周股票复盘：艾力斯（688578）2025年度股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2636612810","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636612810?lang=zh_cn&edition=full","pubTime":"2026-05-17 02:29","pubTimestamp":1778956149,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，艾力斯报收于92.31元，较上周的94.46元下跌2.28%。本周，艾力斯5月12日盘中最高价报97.27元。本周关注点公司公告汇总：艾力斯2025年年度股东会审议通过利润分配预案、董事薪酬、续聘审计机构等多项议案。公司公告汇总上海市通力律师事务所就上海艾力斯医药科技股份有限公司2025年年度股东会的召集和召开程序、出席人员资格、召集人资格、表决程序及表决结果出具法律意见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634496189","title":"中邮证券：给予艾力斯买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2634496189","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634496189?lang=zh_cn&edition=full","pubTime":"2026-05-09 09:55","pubTimestamp":1778291717,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,陈灿近期对艾力斯进行研究并发布了研究报告《Q1业绩超预期，产品矩阵逐步成型》，给予艾力斯买入评级。公司深耕肺癌市场商业化成绩显著，考虑伏美替尼仍有20外插与辅助治疗等适应症拓展空间，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级7家；过去90天内机构目标均价为116.85。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050900004723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630039349","title":"【机构调研记录】蜂巢基金调研艾力斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2630039349","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630039349?lang=zh_cn&edition=full","pubTime":"2026-04-28 08:05","pubTimestamp":1777334748,"startTime":"0","endTime":"0","summary":"蜂巢基金成立于2018年，截至目前，资产管理规模342.19亿元，排名99/212；资产管理规模342.19亿元，排名88/212；管理公募基金数57只，排名102/212；旗下公募基金经理9人，排名113/212。旗下最近一年表现最佳的公募基金产品为蜂巢先进制造混合发起式A，最新单位净值为1.82，近一年增长93.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800026708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630801098","title":"每周股票复盘：艾力斯（688578）Q1净利增54.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630801098","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630801098?lang=zh_cn&edition=full","pubTime":"2026-04-26 03:05","pubTimestamp":1777143913,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，艾力斯报收于95.32元，较上周的97.58元下跌2.32%。本周，艾力斯4月23日盘中最高价报100.7元。本周关注点来自业绩披露要点：艾力斯2026年一季报显示归母净利润6.36亿元，同比上升54.94%。股本股东变化截至2026年3月31日，艾力斯股东户数为2.03万户，较2025年12月31日增加4586.0户，增幅29.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629472140","title":"艾力斯(688578.SH)发布一季度业绩，归母净利润6.36亿元，同比增长54.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629472140","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629472140?lang=zh_cn&edition=full","pubTime":"2026-04-22 22:13","pubTimestamp":1776867225,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾力斯(688578.SH)披露2026年第一季度报告，报告期公司实现营收15.84亿元，同比增长44.19%;归母净利润6.36亿元，同比增长54.94%;扣非净利润6.33亿元，同比增长59.86%。基本每股收益1.41元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾力斯(688578.SH)发布一季度业绩，归母净利润6.36亿元，同比增长54.94%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629472290","title":"艾力斯（688578）披露2026年第一季度报告，4月22日股价上涨2.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629472290","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629472290?lang=zh_cn&edition=full","pubTime":"2026-04-22 22:09","pubTimestamp":1776866957,"startTime":"0","endTime":"0","summary":"截至2026年4月22日收盘，艾力斯报收于97.79元，较前一交易日上涨2.16%，最新总市值为440.06亿元。该股当日开盘95.3元，最高98.05元，最低93.8元，成交额达5.01亿元，换手率为1.16%。近日，上海艾力斯医药科技股份有限公司披露《2026年第一季度报告》。总资产8,586,607,887.04元，归属于上市公司股东的所有者权益7,743,802,875.53元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200054283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622493138","title":"3月27日艾力斯涨5.71%，银华中证创新药产业ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622493138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622493138?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:14","pubTimestamp":1774599252,"startTime":"0","endTime":"0","summary":"证券之星消息，3月27日艾力斯涨5.71%，收盘报96.8元，换手率1.33%，成交量6.0万手，成交额5.71亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共50家，其中持有数量最多的公募基金为银华基金的银华中证创新药产业ETF。银华中证创新药产业ETF目前规模为124.21亿元，最新净值0.7736，较上一交易日下跌1.02%，近一年上涨8.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700033405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","06978","BK0239","159992","688578","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619100708","title":"股市必读：3月13日艾力斯现1笔大宗交易 机构净卖出1521.61万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619100708","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619100708?lang=zh_cn&edition=full","pubTime":"2026-03-16 02:35","pubTimestamp":1773599713,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，艾力斯报收于94.51元，下跌0.37%，换手率0.97%，成交量4.35万手，成交额4.1亿元。当日关注点来自交易信息汇总：3月13日主力资金净流出525.26万元，占总成交额1.28%。大宗交易3月13日艾力斯现1笔大宗交易，机构净卖出1521.61万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600000981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619212077","title":"每周股票复盘：艾力斯（688578）一周现3笔大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2619212077","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619212077?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:33","pubTimestamp":1773513189,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，艾力斯报收于94.51元，较上周的97.33元下跌2.9%。本周，艾力斯3月10日盘中最高价报98.5元。3月9日盘中最低价报92.81元。艾力斯当前最新总市值425.3亿元，在化学制药板块市值排名9/150，在两市A股市值排名477/5190。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619985791","title":"3月13日艾力斯现1笔大宗交易 机构净卖出1521.61万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619985791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619985791?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:23","pubTimestamp":1773393815,"startTime":"0","endTime":"0","summary":"证券之星消息，3月13日艾力斯发生大宗交易，交易数据如下：大宗交易成交价格94.51元，成交16.1万股，成交金额1521.61万元，买方营业部为瑞银证券有限责任公司上海花园石桥路证券营业部，卖方营业部为机构专用。近三个月该股共发生3笔大宗交易，合计成交3610.0手。截至2026年3月13日收盘，艾力斯报收于94.51元，下跌0.37%，换手率0.97%，成交量4.35万手，成交额4.1亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300029684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618187131","title":"3月12日艾力斯现1笔大宗交易 机构净买入948.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618187131","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618187131?lang=zh_cn&edition=full","pubTime":"2026-03-12 17:21","pubTimestamp":1773307302,"startTime":"0","endTime":"0","summary":"证券之星消息，3月12日艾力斯发生大宗交易，交易数据如下：大宗交易成交价格94.86元，成交10万股，成交金额948.6万元，买方营业部为机构专用，卖方营业部为摩根大通证券(中国)有限公司上海银城中路证券营业部。近三个月该股共发生3笔大宗交易，合计成交2952.0手。截至2026年3月12日收盘，艾力斯报收于94.86元，下跌1.06%，换手率0.66%，成交量2.99万手，成交额2.85亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200028426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688578","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782935631322,"stockEarnings":[{"period":"1week","weight":0.3456},{"period":"1month","weight":0.4103},{"period":"3month","weight":0.2751},{"period":"6month","weight":0.2161},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2161}],"compareEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.0135},{"period":"3month","weight":0.0493},{"period":"6month","weight":0.0362},{"period":"1year","weight":0.1893},{"period":"ytd","weight":0.0362}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海艾力斯医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20285人(较上一季度增加29.21%)","perCapita":"22183股","listingDate":"2020-12-02","address":"上海市浦东新区周浦镇凌霄花路268号","registeredCapital":"45000万元","survey":" 上海艾力斯医药科技股份有限公司的主营业务是肿瘤靶向创新药的研发、生产和营销。公司的主要产品是甲磺酸伏美替尼片、枸橼酸戈来雷塞片、普拉替尼胶囊。","listedPrice":22.73},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾力斯(688578)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾力斯(688578)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾力斯,688578,艾力斯股票,艾力斯股票老虎,艾力斯股票老虎国际,艾力斯行情,艾力斯股票行情,艾力斯股价,艾力斯股市,艾力斯股票价格,艾力斯股票交易,艾力斯股票购买,艾力斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾力斯(688578)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾力斯(688578)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}